Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention

NCT07683585 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

207

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hypertension
Coronary Arterial Disease
Percutaneous Coronary Intervention

Interventions

DRUG: Losartan + Hydrochlorothiazide
DRUG: Amlodipine + Azilsartan

Sponsor

National Medical Research Center for Therapy and Preventive Medicine